𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TNF-α expression is transcriptionally regulated by RANK ligand

✍ Scribed by W. Zou; A. Amcheslavsky; S. Takeshita; H. Drissi; Z. Bar-Shavit


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
235 KB
Volume
202
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Tumor necrosis factor (TNF)‐α is known for its osteoclastogenic and resorptive activities. Induction of osteoclastogenesis by receptor activator of NF‐κB ligand (RANKL) is accompanied by increased TNF‐α expression. In the present study we investigated the mechanism by which RANKL induces expression of TNF‐α in osteoclast precursors. The macrophage‐like cell‐line, RAW 264.7 was used as a model for osteoclast precursors. To examine if RANKL‐mediated increase in TNF‐α expression involves increased stability of its transcript, RAW264.7 cells were treated with or without RANKL, and then a transcription inhibitor was added. At different time points, TNF‐α and L32 mRNA levels were examined. TNF‐α mRNA stability was not altered by RANKL. We next measured directly the transcription rate of TNF‐α by a run‐on assay and found that RANKL increases TNF‐α transcription rate by 2.9‐fold in RAW264.7 cells. We further characterized this transcriptional induction of TNF‐α by RANKL. Gel shift assays using nuclear extracts derived from RANKL‐treated RAW264.7 cells show increased specific NF‐κB binding activity on the murine TNF‐α promoter. Gliotoxin, known for its ability to inhibit NF‐κB activation blocked RANKL‐induced TNF‐α expression. We finally used 1,260 bp of the murine TNF‐α promoter fused to luciferase, as well as four mutants of this promoter carrying mutations in each of the four NF‐κB sites to stably transfect RAW 264.7 cells. Reporter activity was increased in response to RANKL in wild type promoter transfected cells, whereas treatment of the mutants' transfected cells did not elicit reporter activity. In conclusion, RANKL induces TNF‐α expression via a transcriptional mechanism, depending on the NF‐κB sites in the TNF promoter. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


TNF receptor type 1 regulates RANK ligan
✍ Yousef Abu-Amer; Sabiha Abbas; Teruhisa Hirayama 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

## Abstract TNFα is a major osteoclastogenic cytokine and a primary mediator of inflammatory osteoclastogenesis. We have previously shown that this cytokine directly targets osteoclasts and their precursors and that deletion of its type‐1 receptor (TNFr1) lessens osteoclastogenesis and impacts RANK

Expression of prostate-specific antigen
✍ Joanne N. Davis; Omer Kucuk; Fazlul H. Sarkar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Prostate cancer is the second-leading cause of cancer-related deaths in men in the United States. Unfortunately, there is no effective therapy when prostate cancer becomes metastatic and refractory to conventional treatments. For this reason, the identification and exploration of new agents that red

Novel surface expression of reticulocalb
✍ Carlton R. Cooper; Bianca Graves; Freddie Pruitt; Hassan Chaib; Jill E. Lynch; A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract An unbiased cDNA expression phage library derived from bone‐marrow endothelial cells was used to identify novel surface adhesion molecules that might participate in metastasis. Herein we report that reticulocalbin 1 (RCN1) is a cell surface‐associated protein on both endothelial (EC) an